The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia
Semin Hematol
.
2004 Oct;41(4 Suppl 6):1-3.
doi: 10.1053/j.seminhematol.2004.08.001.
Author
Joseph DeSimone
PMID:
15799099
DOI:
10.1053/j.seminhematol.2004.08.001
No abstract available
Publication types
Editorial
MeSH terms
Anemia, Sickle Cell / drug therapy*
DNA Methylation / drug effects*
Fetal Hemoglobin / analysis
Fetal Hemoglobin / drug effects
Fetal Hemoglobin / genetics
Humans
Thalassemia / drug therapy*
Substances
Fetal Hemoglobin